THE MORAL CALCULUS OF PHARMA COMPANIES IN INDIA

Authors

  • CRESENTA SHAKILA MOTHA L SASTRA University
  • Nalini R SASTRA University
  • ALAMELU R SASTRA University
  • AMUDHA R SASTRA University

Abstract

To comprehend whether corporate social responsibility (CSR) in pharma is more of a corporate hypocrisy where firms and organizations tend to
marginalize their employees and the environment at large. The present study is case based, and an attempt has been made to analyze probable driving
reasons behind the corporate behavior exhibited by pharma industries. CSR is understood differently by different beneficiaries but usually refers to
serving the citizens, population of communities, and the larger society in a way that goes beyond what is legally required of a firm. Though numerous
programs and schemes have been launched for their upliftment, it is all an eye wash which is intended for the internal benefit of the organization.
Corporate these days, as per the Companies Act should report spend of 2% of their profits as pronounced in the CSR and pharmaceutical companies
are no exemption to it. As per Section 135 of the Companies Act 2013, it is recommended that companies having revenue above Rs. 1,000 crore and
profit more than Rs. 5 crore should report what they spend for CSR. Companies these days often utilize CSR as a brand building exercise, engagement
of employees, helping the local community around their firm, or even as a fame generating spot for the themes of the chairman's spouse. Thus, it is
obvious that the social responsibility of pharmaceutical business sector is mainly to increase their profit, increase their shareholder activism, and
investment in the community.
Keywords: Corporate social responsibility, Hypocrisy, Pharmaceutical industries, Society and organization.

Downloads

Download data is not yet available.

References

REFERENCES

Available from: http://www.pharmabiz.com/ArticleDetails.

aspx?aid=90147&sid=1.

Friedman M. The Social Responsibility of Business is to Increase its

Profits. The New York Times Magazine. https:// www.colorado.edu/

studentgroups/.../friedman-soc-resp-business.html. [Last retrieved on

Jul 03].

Our Cry for Life. Latin American Theology from the Perspective of

Women ( San Jose, Costa Rica:Ecumenical Department of Research ,

, et al.

Ganguly S. The Investor-State Dispute Mechanism (ISDM) and a

Sovereign’s power to protect public health. Columbia J Trans Law

;38:113.

McKibben B. Hope vs. Hype. Mother Jones. [Last retrieved on 2008 Jul

.

Porter ME, Kramer MR. The competitive advantage of corporate

philanthropy. Harv Bus Rev 2002;80(12):56-68, 133.

United Nations (UN). Global Compact: Corporate Sustainability in the

World Economy. 2014. Available from: https://www.unglobalcompact.

org/index.html. [Last accessed on 2014 Apr 25].

Leisinger KM. The corporate social responsibility of the pharmaceutical

industry: Idealism without illusion and realism without resignation. Bus

Ethics Q 2005;15(4):577-94. doi: 10.5840/beq200515440.

Lee M, Kohler J. Benchmarking and transparency: Incentives for the

pharmaceutical Industry’s corporate social responsibility. J Bus Ethics

;95:641-58. doi: 10.1007/s10551-010-0444-y.

Pharma TA. CSR: Why good deeds are good business. Eye Pharm 2011.

Available from: http://www.social.eyeforpharma.com/commercial/

pharma-and-csr-why-good-deeds-are-good-business. [Last accessed on

Apr 09].

Armstrong JS, Green KC. Effects of corporate social responsibility and

irresponsibility policies. J Business Res 2013;66(12):2369-6.

Hwang JJ. Is Merck’s Corporate Social Responsibility Good for the

Global Health? U of California, San Diego; 2012. Available from:

http://www.irps.ucsd.edu/assets/001/503692.pdf. [Last accessed on

Mar 20].

Gruskin S, Raad Z. Are drug companies living up to their human

rights responsibilities? Moving toward assessment. PLoS Med

;7(9):e1000310.

Lee JY, Hunt P. Human rights responsibilities of pharmaceutical

companies in relation to access to medicines. J Law Med Ethics

;40(2):220-33.

Ritter GS. Are drug companies living up to their human

rights responsibilities? The Merck perspective. PLoS Med

;7(9):e1000343.

PLoS Medicine Editors. Drug companies should be held more

accountable for their human rights responsibilities. PLoS Med

;7(9):e1000344.

Blowfield M, Frynas JG. Setting new agendas: Critical perspectives

on corporate social responsibility in the developing world. Int Affairs

;81:499-513.

Hopkins M. Corporate Social Responsibility: Is Business the Solution?

London: Earthscan; 2007.

Big Pharma’s Dirty Tricks. (n.d.). Available from: http://www.

downtoearth.org.in/blog/big-pharmas-dirty-tricks-38830.

Ethics on trial. (n.d.). Available from: http://www.downtoearth.org.in/

coverage/ethics-on-trial-33605. [Last retrieved on 2016 Jan 20].

Available from: http://www.downtoearth.org.in/coverage/ethics-ontrial-No

one liable for trial mishap-33605.

Available from: http://www.downtoearth.org.in/coverage/ethics-ontrial-

Bill

shows the way

-33605.

Available from: http://www.deccanchronicle.com/151210/nationcurrent

affairs/article/csir%E2%80%99s-move-develop-indiantamiflu.

Available from: http://www.timesofindia.indiatimes.com/

city/lucknow/In-UP-80-of-people-with-HIV-are-untreated/

articleshow/50194262 cms.

Available from: http://www.timesofindia.indiatimes.com/city/

ahmedabad/68-die-of-cancer-every-day-in-Gujarat-Report/

articleshow/50131274.cms.

Available from: http://www.downtoearth.org.in/news/no-more-

freebiesto-doctors-gsk-43128.

Available from: http://www.downtoearth.org.in/news/no-more-

freebiesto-doctors- industry view -gsk-43128.

Available from: https://www.jacobinmag.com/2013/06/socialize-big-

pharma/.

Available from: http://www.businesstoday.in/magazine/features/indian-

bulk-drug-makers-becoming-world-leaders-niche-areas/story/210082.

html.

Available from: http://www.rediff.com/news/interview/ayurvedais-medicine-with-intelligence-modern-medicine-is-like-abullet/20141118.html.

Available from: http://www.economictimes.indiatimes.com/industry/

healthcare/biotech/pharmaceuticals/govt-looking-into-suggestions-tostrengthen-bulk-drugs-sector/articleshow/50186554.cms.

Published

01-03-2016

How to Cite

MOTHA L, C. S. ., N. R, A. . R, and A. . R. “THE MORAL CALCULUS OF PHARMA COMPANIES IN INDIA”. Asian Journal of Pharmaceutical and Clinical Research, vol. 9, no. 2, Mar. 2016, pp. 30-33, https://mail.innovareacademics.in/journals/index.php/ajpcr/article/view/10445.

Issue

Section

Review Article(s)